Netherlands Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Dutch pharmaceuticals market had total revenues of $6.0 billion in 2022, representing a compound annual growth rate (CAGR) of 2.9% between 2017 and 2022.
- 0
- According to in-house research, in 2022, Germany accounted for 1.7% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in Dutch stood at 6.2% of total health spending in 2021.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in the Netherlands
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts
- What was the size of the Netherlands pharmaceuticals market by value in 2022?
- What will be the size of the Netherlands pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up the Netherlands's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths of leading players?
- 7.3. What strategies do leading players follow?
- 8 Company Profiles
- 8.1. Novartis AG
- 8.2. Pfizer Inc.
- 8.3. AstraZeneca PLC
- 8.4. GSK plc.
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Netherlands pharmaceuticals market value: $ billion, 2017-22
- Table 2: Netherlands pharmaceuticals market geography segmentation: $ billion, 2022
- Table 3: Netherlands pharmaceuticals market value forecast: $ billion, 2022-27
- Table 4: Novartis AG: key facts
- Table 5: Novartis AG: Annual Financial Ratios
- Table 6: Novartis AG: Key Employees
- Table 7: Novartis AG: Key Employees Continued
- Table 8: Pfizer Inc.: key facts
- Table 9: Pfizer Inc.: Annual Financial Ratios
- Table 10: Pfizer Inc.: Key Employees
- Table 11: Pfizer Inc.: Key Employees Continued
- Table 12: AstraZeneca PLC: key facts
- Table 13: AstraZeneca PLC: Annual Financial Ratios
- Table 14: AstraZeneca PLC: Key Employees
- Table 15: AstraZeneca PLC: Key Employees Continued
- Table 16: GSK plc.: key facts
- Table 17: GSK plc.: Annual Financial Ratios
- Table 18: GSK plc.: Key Employees
- Table 19: GSK plc.: Key Employees Continued
- Table 20: Netherlands size of population (million), 2018-22
- Table 21: Netherlands gdp (constant 2005 prices, $ billion), 2018-22
- Table 22: Netherlands gdp (current prices, $ billion), 2018-22
- Table 23: Netherlands inflation, 2018-22
- Table 24: Netherlands consumer price index (absolute), 2018-22
- Table 25: Netherlands exchange rate, 2018-22
- List of Figures
- Figure 1: Netherlands pharmaceuticals market value: $ billion, 2017-22
- Figure 2: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2022
- Figure 3: Netherlands pharmaceuticals market value forecast: $ billion, 2022-27
- Figure 4: Forces driving competition in the pharmaceuticals market in the Netherlands, 2022
- Figure 5: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2022
- Figure 6: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2022
- Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2022
- Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2022
- Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2022
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook